Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Zymo Research Receives Exclusive Licensing Agreement for Epigenetic Aging Clock Technology

Zymo Research Corp.
Posted on: 18 Oct 16

PR Newswire

VANCOUVER, British Columbia, Oct. 18, 2016

VANCOUVER, British Columbia, Oct. 18, 2016 /PRNewswire/ -- Zymo Research Corp. announced today, during the ASHG 2016 Annual Meeting, that it has obtained an exclusive license for a methylation age predictor, also known as Horvath's Clock, so named for Dr. Steve Horvath, a professor of human genetics and biostatistics at the David Geffen School of Medicine at UCLA and Fielding School of Public Health, who is the developer of the epigenetic clock. Dr. Horvath examined the relationship between DNA methylation and aging. The Horvath Clock uses sample DNA from any biological source (such as adipose tissue, bladder, blood, various organs, etc.), other than sperm, to measure DNA methylation based on 353 epigenetic markers from the human genome. The clock estimates the biological age of most human tissues and cell types.

The epigenetic clock can be used for forensic, consumer or academic applications. Dr. Graham Threadgill, Vice President of Global Marketing at Zymo Research said, "The Horvath Clock is an important part of Zymo Research's aging program. We plan to commercialize products in the future based on the epigenetic clock and other related markers. We are excited to be at the forefront of this new field of research and look forward to expanding Zymo's presence in the field of epigenetic analysis."

Dr. Horvath's research in 2013 led him down the path to learn more about the process of human aging and how to slow it down. His Horvath Clock is a tool that compares the biological age of any tissue to its chronological age with consistently accurate results. The epigenetic clock could be used in a broad range of research, such as cancer or stem cell, to offer researchers valuable insights about the biological age of tissues and cell types.

About Zymo Research Corporation
Zymo Research Corporation, also known as "The Epigenetics Company", is a privately held company based in Irvine, California, USA. Since its inception in 1994 it has been serving the academic and biopharmaceutical scientific communities by providing DNA and RNA purification products. Zymo Research was an early adopter in the field of epigenetics and offers a line of products used in DNA methylation detection and quantitation. In addition to the epigenetic and nucleic acid purification products, Zymo also provides genetic, epigenetic and transcriptome analysis services. For more information, please visit: Follow Zymo Research Corporation on Facebook, LinkedIn,Twitter, and Instagram.

All trademarks are the property of their respective owners. Zymo Research Corporation, the stylized logo, and the tagline "The Beauty of Science is to Make Things Simple" are trademarks of Zymo Research Corporation and are registered with the USPTO.


Photo -
Logo -


To view the original version on PR Newswire, visit:

SOURCE Zymo Research Corp.

PR Newswire

Last updated on: 18/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.